Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis

• Published in: Radiation oncology (London, England) Vol. 18; no. 1; pp. 63 - 10
• Main Authors: Xu, An-An, Miao, Jing-Jing, Wang, Lin, Li, An-Chuan, Han, Fei, Shao, Xun-Fan, Mo, Zhi-Wen, Huang, Shao-Min, Yuan, Ya-Wei, Deng, Xiao-Wu, Zhao, Chong
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.04.2023; BioMed Central; BMC
• Subjects: Biopsy; Brain damage; Cancer; Care and treatment; Chemoradiotherapy; Chemoradiotherapy - methods; Chemotherapy; Cisplatin; Clinical trials; Concurrent chemotherapy; Deafness; Death; Diagnosis; Distribution; Failure; Follow-Up Studies; Health hazards; Heterogeneity; Humans; Intensity-modulated radiotherapy; Magnetic resonance imaging; Medical prognosis; Metastasis; Methods; Mortality; Nasopharyngeal cancer; Nasopharyngeal carcinoma; Nasopharyngeal Carcinoma - radiotherapy; Nasopharyngeal Neoplasms - radiotherapy; Neck; Otitis; Patient outcomes; Patients; Peripheral neuropathy; Prognosis; Prognostication; Radiation therapy; Radiotherapy; Radiotherapy, Intensity-Modulated - methods; Rank tests; Retrospective Studies; Risk; Risk groups; Soft tissues; Statistical analysis; Statistical models; Statistical tests; Subgroups; Survival; Temporal lobe; Throat cancer; Tomography; Toxicity; Tumor staging; Xerostomia; China; Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Prognostication; Toxicity; Concurrent chemotherapy

To analysis the clinical outcomes of concurrent chemoradiotherapy (CCRT) alone based on 10-year results for loco-regionally advanced nasopharyngeal carcinoma (LANPC), so as to provide evidence for individualized treatment strategy and designing appropriate clinical trial for different risk LANPC pat...